期刊
CLINICAL AND MOLECULAR HEPATOLOGY
卷 21, 期 4, 页码 344-348出版社
KOREAN ASSOC STUDY LIVER
DOI: 10.3350/cmh.2015.21.4.344
关键词
Drug eluting beads; Hepatocellular carcinoma; Transarterial chemoembolization
资金
- 2-year Research Grant of Pusan National University
Transarterial chemoembolization (TACE) using doxorubicin-eluting beads (DEBs) have been introduced as a novel device which ensures more sustained and tumor-selective drug delivery and permanent embolization compared to conventional TACE with lipiodol. Studies highlighting the use of TACE with DEBs for the treatment of hepatocellular carcinoma (HCC) have shown similar or better results compared to conventional TACE with lipiodol. TACE with DEBs is increasingly being performed interchangeably with conventional TACE. This review assessed the characteristics, clinical outcomes and future direction of TACE with DEBs compared to conventional TACE.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据